Order over $250 get free 2-day shipping
Order over $250 get free 2-day shipping
Email
Call

LL-37

The human cathelicidin-derived host-defense peptide with activity against a wide spectrum of microbes and a major role in innate immune modulation. Research focuses include chronic wounds, biofilms, infections, inflammatory skin and mucosal diseases, and the dual roles of LL-37 in antimicrobial defense and inflammatory signaling.
For research use only – not for human or veterinary use, diagnosis, or treatment.

$80.00

Additional information

Weight 0.1 lbs
Strength

5mg

Volume

3ML

LL-37 is a synthetic antimicrobial peptide derived from the human cathelicidin protein (hCAP-18), studied in controlled laboratory environments for its interaction with innate immune signaling pathways and membrane-active mechanisms. As a cationic host defense peptide, LL-37 has been investigated for its role in microbial membrane disruption research, immunomodulatory signaling models, and inflammatory pathway regulation frameworks. Due to its broad-spectrum biological activity profile, it remains a compound of interest in immunology and cellular defense research.

Preclinical investigations have examined LL-37 for its influence on chemotactic signaling pathways, cytokine modulation research, and epithelial barrier function models. Ongoing scientific studies continue to evaluate its receptor-independent membrane interactions, intracellular immune signaling cascades, and antimicrobial mechanism dynamics within strictly controlled experimental settings.

This research peptide is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. LL-37 is intended strictly for laboratory research and analytical purposes only and is not for human consumption.

  • Cathelicidin-derived antimicrobial peptide research
  • Studied for innate immune signaling pathway interaction
  • Investigated in microbial membrane activity models
  • Evaluated in cytokine and chemotactic signaling research
  • Explored in epithelial barrier and inflammatory frameworks
  • Research-grade LL-37 peptide
  • High-purity synthesis protocols
  • Analytical verification (HPLC tested)
  • Batch-specific quality control procedures
  • Secure, laboratory-compliant packaging
This product is intended for laboratory research use only. It is not approved for human consumption, therapeutic application, or diagnostic purposes.

Questions

Common questions about research peptides, ordering, and lab standards

What is LL-37 commonly studied for in research?

LL-37 is studied for its role in innate immune signaling and antimicrobial membrane interaction research models.

What is LL-37 derived from?

LL-37 is derived from the human cathelicidin protein (hCAP-18) and is investigated as a host defense peptide in laboratory settings.

What format is available for this product?

This LL-37 research peptide is supplied in a 5mg presentation within a 3ML vial.

Is LL-37 analytically tested?

Yes, each batch undergoes analytical verification such as HPLC testing to confirm purity and structural consistency.

Is LL-37 intended for human use?

No. LL-37 is strictly intended for laboratory research purposes only and is not approved for human consumption.
×
Summer Sale Summer Sale
×

Choose the discount code below that fits your research needs.

Individual Products (35% OFF)
SUMMER35
Bulk 5 & 10 Kits (20% OFF)
SUMMER20
Site Entrance Logo

Age Verification

Access to our catalog requires a minimum of 21 years of cellular replication on Earth. Please confirm your maturation level to enter the lab.